Donald J. Cook - Concepedia

Author

Donald J. Cook

AstraZeneca (United States)

Also Known As

D Cook, D. Cook, D. J. COOK, D. J. Cook, D.J. Cook, Donald Cook, Donald J. Cook

Publications

347

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Bristol-Myers Squibb (United States)

About

Donald J. Cook is an author at AstraZeneca (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	221
2	Natural Sciences	4	4	137
3	Biochemistry	2	2	59
4	Biology	1	1	47
5	Cell Biology	1	1	31

Donald J. Cook

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582) Edward J. Hennessy, Ammar Adam, Brian Aquila, Journal of Medicinal Chemistry Compound 14ApoptosisCell DeathPharmacotherapyTumor Biology	2013	112
The discovery of BMS-275183: an orally efficacious novel taxane Harold Mastalerz, Donald J. Cook, Craig R. Fairchild, Bioorganic & Medicinal Chemistry BiologyNatural SciencesMolecular BiologySecondary MetaboliteEfficacious Novel Taxane	2003	47
Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase David A. Scott, Carrie L. Balliet, Donald J. Cook, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2008	37
Discovery and Optimization of a Novel Series of Potent Mutant B-Raf<sup>V600E</sup> Selective Kinase Inhibitors Melissa M. Vasbinder, Brian Aquila, Martin Augustin, Journal of Medicinal Chemistry Drug TargetMolecular BiologyChemical BiologyPharmaceutical ChemistryTumor Biology	2013	31
Facile Synthesis of a Simplified Bicyclo[7.3.1] Esperamicin-Calicheamicin Enediyne Core John F. Kadow, Donald J. Cook, Terrence W. Doyle, Tetrahedron PharmacologyOrganic ChemistrySynthetic ChemistrySimplified Bicyclo	1994	28
Preface James T. Doluisio, L.J. Leeson, Anthony J. Glazko, Pharmacology	1972	26
3-Amido-4-anilinoquinolines as CSF-1R kinase inhibitors 2: Optimization of the PK profile David A. Scott, Kirsten Bell, Cheryl T. Campbell, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2008	22
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer David A. Scott, Brian Aquila, Geraldine Bebernitz, Bioorganic & Medicinal Chemistry Letters MedicinePharmacologyPharmacotherapyAnti-cancer AgentCancer Treatment	2008	19

Page 1